Search - tctmd.com

Displaying 1 - 20 of 66

Sort: Relevancy | Date

Presentation TCT 2025

Surgical Intervention and CABG with use of Cangrelor

Presenter: Jennifer Rymer

October 28, 2025

Presentation TCT 2025

High risk / CTO PCI with use of Cangrelor

Presenter: Duk-Woo Park

October 28, 2025

Presentation TCT 2025

ACS (high risk NSTEMI) with use of Cangrelor

Presenter: Evan Shlofmitz

October 28, 2025

Presentation TCT 2025

DAPT -Shock-AMI with use of Cangrelor

Presenter: Babar Basir

October 28, 2025

Presentation TCT India 2025

CANGRELOR New kid in anti-platelet therapy: where to prefer & what are its advantages

Presenter: S. Manoj

July 26, 2025

Presentation TCT 2024

Surgical Interventions and CABG

Presenter: Jennifer Rymer

October 29, 2024

Presentation TCT 2024

Cardiogenic Shock and Use of Cangrelor

Presenter: Babar Basir

October 29, 2024

Presentation TCT 2024

High-risk PCI and Use of Cangrelor

Presenter: Lindsey Cilia

October 29, 2024

Presentation TCT 2024

Cardiac Arrest and Use of Cangrelor

Presenter: Megha Prasad

October 29, 2024

Presentation TCT 2024

TCT 299: Cangrelor Use in Acute Myocardial Infarction Patients Awaiting Coronary Artery Bypass Grafting

Presenter: Jennifer Rymer

October 29, 2024

Presentation TCT 2024

TCT 784: Gender Disparities in Cangrelor Outcomes for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Presenter: Waiel Abusnina

October 29, 2024

Presentation TCT 2024

TCT 174: High Bleeding Risk and Outcomes in Acute Coronary Syndrome After Percutaneous Coronary Intervention With Versus Without Cangrelor

Presenter: Patrick Creechan

October 28, 2024

Presentation TCT 2024

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

Presenter: Angelo Oliva

October 27, 2024

Presentation TCT 2024

TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor

Presenter: Andrew Hill

October 27, 2024

Presentation TCT 2024

TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI

Presenter: Federico Oliveri

October 27, 2024

Presentation TCT 2024

TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application)

Presenter: Guy Friedrich

October 27, 2024

Presentation TCT 2024

TCT 236: Bailout Use of Cangrelor During Percutaneous Coronary Intervention and Associated Inpatient Outcomes

Presenter: Abhishek Chaturvedi

October 27, 2024

Presentation TCT 2023

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Presenter: Michael Savage

October 25, 2023

Presentation TCT 2023

Cangrelor Reduces Procedural Complications and Should Be the Default Strategy

Presenter: Jennifer Rymer

October 25, 2023

Presentation TCT 2020

TCT 065: Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Early Results From the Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes (CAMEO) Registry

Presenter: Jennifer Rymer

October 14, 2020

Advertisement

Surgical Intervention and CABG with use of Cangrelor

High risk / CTO PCI with use of Cangrelor

ACS (high risk NSTEMI) with use of Cangrelor

DAPT -Shock-AMI with use of Cangrelor

CANGRELOR New kid in anti-platelet therapy: where to prefer & what are its advantages

Surgical Interventions and CABG

Cardiogenic Shock and Use of Cangrelor

High-risk PCI and Use of Cangrelor

Cardiac Arrest and Use of Cangrelor

TCT 299: Cangrelor Use in Acute Myocardial Infarction Patients Awaiting Coronary Artery Bypass Grafting

TCT 784: Gender Disparities in Cangrelor Outcomes for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

TCT 174: High Bleeding Risk and Outcomes in Acute Coronary Syndrome After Percutaneous Coronary Intervention With Versus Without Cangrelor

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

TCT 1: Differential Outcomes in ST-Elevation and Non-ST Elevation Myocardial Infarction Outcomes After Percutaneous Coronary Intervention With Versus Without Cangrelor

TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI

TCT 238: Safety and Efficacy of Cangrelor: A Multicenter Nationwide Registry ARECA (Austrian Registry for Cangrelor Application)

TCT 236: Bailout Use of Cangrelor During Percutaneous Coronary Intervention and Associated Inpatient Outcomes

I Don’t Need Cangrelor With Available Potent Oral P2Y12 or 2b3a Inhibitors

Cangrelor Reduces Procedural Complications and Should Be the Default Strategy

TCT 065: Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Early Results From the Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes (CAMEO) Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content